RESUMEN
Griseofulvin was considered an effective agent for cancer therapy in past decades. Although the negative effects of griseofulvin on microtubule stability are known, the exact target and mechanism of action in plants remain unclear. Here, we used trifluralin, a well-known herbicide targeting microtubules, as a reference and revealed the differences in root tip morphology, reactive oxygen species production (ROS), microtubule dynamics, and transcriptome analysis between Arabidopsis treated with griseofulvin and trifluralin to elucidate the mechanism of root growth inhibition by griseofulvin. Like trifluralin, griseofulvin inhibited root growth and caused significant swelling of the root tip due to cell death induced by ROS. However, the presence of griseofulvin and trifluralin caused cell swelling in the transition zone (TZ) and meristematic zone (MZ) of root tips, respectively. Further observations revealed that griseofulvin first destroyed cortical microtubules in the cells of the TZ and early elongation zone (EZ) and then gradually affected the cells of other zones. The first target of trifluralin is the microtubules in the root MZ cells. Transcriptome analysis showed that griseofulvin mainly affected the expression of microtubule-associated protein (MAP) genes rather than tubulin genes, whereas trifluralin significantly suppressed the expression of αß-tubulin genes. Finally, it was proposed that griseofulvin could first reduce the expression of MAP genes, meanwhile increasing the expression of auxin and ethylene-related genes to disrupt microtubule alignment in root tip TZ and early EZ cells, induce dramatic ROS production, and cause severe cell death, eventually leading to cell swelling in the corresponding zones and inhibition of root growth.
Asunto(s)
Proteínas de Arabidopsis , Arabidopsis , Tubulina (Proteína)/metabolismo , Arabidopsis/metabolismo , Griseofulvina/farmacología , Griseofulvina/metabolismo , Trifluralina/metabolismo , Trifluralina/farmacología , Especies Reactivas de Oxígeno/metabolismo , Microtúbulos/metabolismo , Proteínas de Arabidopsis/genética , Proteínas de Arabidopsis/metabolismo , Proteínas Asociadas a Microtúbulos/genética , Proteínas Asociadas a Microtúbulos/metabolismo , Raíces de Plantas/metabolismoRESUMEN
Extra copies of centrosomes are frequently observed in cancer cells. To survive and proliferate, cancer cells have developed strategies to cluster extra-centrosomes to form bipolar mitotic spindles. The aim of this study was to investigate whether centrosome clustering (CC) inhibition (CCi) would preferentially radiosensitize non-small cell lung cancer (NSCLC). Griseofulvin (GF; FDA-approved treatment) inhibits CC, and combined with radiation treatment (RT), resulted in a significant increase in the number of NSCLC cells with multipolar spindles, and decreased cell viability and colony formation ability in vitro. In vivo, GF treatment was well tolerated by mice, and the combined therapy of GF and radiation treatment resulted in a significant tumor growth delay. Both GF and radiation treatment also induced the generation of micronuclei (MN) in vitro and in vivo and activated cyclic GMP-AMP synthase (cGAS) in NSCLC cells. A significant increase in downstream cGAS-STING pathway activation was seen after combination treatment in A549 radioresistant cells that was dependent on cGAS. In conclusion, GF increased radiation treatment efficacy in lung cancer preclinical models in vitro and in vivo. This effect may be associated with the generation of MN and the activation of cGAS. These data suggest that the combination therapy of CCi, radiation treatment, and immunotherapy could be a promising strategy to treat NSCLC.
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas , Neoplasias Pulmonares , Animales , Ratones , Griseofulvina/farmacología , Griseofulvina/metabolismo , Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Carcinoma de Pulmón de Células no Pequeñas/radioterapia , Carcinoma de Pulmón de Células no Pequeñas/metabolismo , Neoplasias Pulmonares/patología , Centrosoma , NucleotidiltransferasasRESUMEN
Penicilium griseofulvum, the causal agent of apple blue mold, is able to produce in vitro and on apple a broad spectrum of secondary metabolites (SM), including patulin, roquefortine C and griseofulvin. Among them, griseofulvin is known for its antifungal and antiproliferative activity, and has received interest in many sectors, from medicine to agriculture. The biosynthesis of SM is finely regulated by filamentous fungi and can involve global regulators and pathway specific regulators, which are usually encoded by genes present in the same gene cluster as the backbone gene and tailoring enzymes. In the griseofulvin gene cluster, two putative transcription factors were previously identified, encoded by genes gsfR1 and gsfR2, and their role has been investigated in the present work. Analysis of P. griseofulvum knockout mutants lacking either gene suggest that gsfR2 forms part of a different pathway and gsfR1 exhibits many spectra of action, acting as regulator of griseofulvin and patulin biosynthesis and influencing conidia production and virulence on apple. The analysis of gsfR1 promoter revealed that the regulation of griseofulvin biosynthesis is also controlled by global regulators in response to many environmental stimuli, such as carbon and nitrogen. The influence of carbon and nitrogen on griseofulvin production was further investigated and verified, revealing a complex network of response and confirming the central role of gsfR1 in many processes in P. griseofulvum.
Asunto(s)
Griseofulvina/biosíntesis , Patulina/biosíntesis , Penicillium/metabolismo , Penicillium/patogenicidad , Esporas Fúngicas/crecimiento & desarrollo , Carbono/metabolismo , Microbiología de Alimentos , Griseofulvina/metabolismo , Malus/microbiología , Familia de Multigenes , Nitrógeno/metabolismo , Patulina/metabolismo , Esporas Fúngicas/metabolismo , Factores de Transcripción/genética , VirulenciaRESUMEN
PURPOSE: Mucins are the principal glycoproteins in mucus and have been implicated in the limitation of intestinal drug absorption; however, the contribution of these molecules to intestinal drug absorption remains unclear. In this study, the relationship between the effect of the mucus layer on intestinal drug permeation and mucin distribution in different parts of the rat gastrointestinal tract was evaluated. METHODS: The intestinal permeability of various lipophilic drugs in rat small intestine was evaluated using the in vitro sac method. The expression profiles of mucin mRNA and proteins were evaluated by quantitative real-time RT-PCR and western blotting, respectively. RESULTS: The intestinal permeability of griseofulvin and antipyrine was enhanced by dithiothreitol (DTT) treatment in the proximal small intestine, such as duodenum and jejunum, but not in the distal regions. The mRNA expression analysis of rat mucin genes revealed that the intestinal expression of Muc5ac was considerably higher in the duodenum, whereas that of Muc1, Muc2, and Muc3A was gradually increased toward the lower intestine. In addition, Muc5ac protein was detected only in the luminal fluids from the proximal small intestine after DTT treatment. CONCLUSIONS: Mucus limits the intestinal permeation of lipophilic drugs in the rat proximal small intestine, in which Muc5ac may be involved.
Asunto(s)
Antipirina/farmacología , Griseofulvina/farmacología , Intestino Delgado/metabolismo , Liposomas , Glicoproteínas de Membrana/metabolismo , Mucinas/metabolismo , Animales , Antipirina/metabolismo , Composición de Medicamentos , Griseofulvina/metabolismo , Absorción Intestinal , Mucinas/genética , RatasRESUMEN
This proof-of-concept study explores the feasibility of using a drug-loaded hydrophilic polymeric layer sandwiched between two hydrophobic layers for improving film drug load while achieving sustained release of poorly water-soluble drug. Such films having total thickness in range ~ 146-250 µm were prepared by slurry-based casting using hydrophilic hydroxypropyl methylcellulose (HPMC) as matrix layer containing fenofibrate (FNB) as the model drug, encased between two very thin rate-limiting layers of 10 µm each of hydrophobic poly-É-caprolactone (PCL). Film precursor slurry consisted of HPMC with plasticizer and water along with micronized FNB powders, which were dry-coated with hydrophilic silica. Characterization techniques demonstrated the presence of homogeneously dispersed crystalline FNB in films. The films are very thin and hence two-dimensional; hence, average drug load per unit area in range ~ 5 to ~ 9 mg/cm2 could be achieved by altering the thickness of the drug matrix layer. Drug amount and drug content uniformity were measured through assay of ten circular samples ~ 0.712 cm2 in area punched out using a circular-shaped punch tool. Drug release rate was investigated using USP IV flow-through cell and surface dissolution imaging system. Thinner films followed Fickian diffusion, and thicker films followed non-Fickian anomalous diffusion. Overall, the application of middle layer thickness could be used as a tool to manipulate drug load without the need for altering its formulation or precursor preparation by changing its thickness, hence achieving relatively high drug loading yet having sustained release of drug.
Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Liberación de Fármacos , Interacciones Hidrofóbicas e Hidrofílicas , Polímeros/química , Agua/química , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/metabolismo , Griseofulvina/química , Griseofulvina/metabolismo , Derivados de la Hipromelosa/química , Derivados de la Hipromelosa/metabolismo , Nanopartículas/química , Nanopartículas/metabolismo , Polímeros/metabolismo , Solubilidad , Agua/metabolismo , Difracción de Rayos X/métodosRESUMEN
Sclerotinia sclerotiorum is responsible for the white mold of soybeans, and the difficulty to control the disease in Brazil is causing million-dollar damages. Stachybotrys levispora has shown activity against S. sclerotiorum. In our present investigation, we analyzed the chemical basis of this inhibition. Eight compounds were isolated, and using spectroscopic methods, we identified their structures as the known substances 7-dechlorogriseofulvin, 7-dechlorodehydrogriseofulvin, griseofulvin, dehydrogriseofulvin, 3,13-dihydroxy-5,9,11-trimethoxy-1-methylbenzophenone, griseophenone A, 13-hydroxy-3,5,9,11-tetramethoxy-1-methylbenzophenone, and 12-chloro-13-hydroxy-3,5,9,11-tetramethoxy-1-methylbenzophenone. Griseofulvin inhibited the mycelial growth of S. sclerotiorum at 2 µg mL-1. Thus, the antagonistic effect of S. levispora to S. sclerotiorum may well be due to the presence of griseofulvins. Our results stimulate new work on the biosynthesis of griseofulvins, to locate genes that encode key enzymes in these routes and use them to increase the production of these compounds and thus potentiate the fungicide effect of this fungus. S. levispora represents an agent for biocontrol, and griseofulvin represents a fungicide to S. sclerotiorum.
Asunto(s)
Ascomicetos/efectos de los fármacos , Fungicidas Industriales/farmacología , Griseofulvina/farmacología , Enfermedades de las Plantas/prevención & control , Stachybotrys/química , Ascomicetos/fisiología , Brasil , Proteínas Fúngicas/genética , Proteínas Fúngicas/metabolismo , Fungicidas Industriales/química , Fungicidas Industriales/metabolismo , Griseofulvina/química , Griseofulvina/metabolismo , Enfermedades de las Plantas/microbiología , Glycine max/microbiología , Stachybotrys/genética , Stachybotrys/metabolismoRESUMEN
The precipitation inhibitory effect of cellulosic polymers in relation to their physicochemical properties was studied. Using a poorly water-soluble model drug, griseofulvin, the precipitation inhibitory effect of a series of hydroxypropyl methylcellulose (HPMC) and methylcellulose polymers was studied using solvent-shift method. The extent of supersaturation maintenance of each polymer was then quantified by the parameter, supersaturation factor (SF). Partial least square (PLS) regression analysis was employed to understand the relative contribution from viscosity, hydroxypropyl content (HC), methoxyl content, methoxyl/hydroxypropyl ratio, and drug-polymer interaction parameter (χ) on SF. All grades of cellulosic polymers effectively prolonged supersaturation of griseofulvin. PLS regression analysis revealed that HC and χ appeared to have the strongest influence on SF response. A regression model of SF = 1.65-0.16 χ + 0.05 HC with a high correlation coefficient, r of 0.921, was obtained. Since the value of χ is inversely related to the strength of drug-polymer interaction, the result shows that SF increases with increasing drug-polymer interaction and increasing HC. As such, it can be implied that strong drug-polymer interaction and presence of hydroxypropyl groups in cellulosic polymers for hydrogen bonding are two key parameters for effective supersaturation maintenance. This knowledge on the relative contribution of polymer physicochemical properties on precipitation inhibition will allow the selection of suitable cellulosic polymers for systematic development of supersaturating drug delivery systems.
Asunto(s)
Griseofulvina/química , Derivados de la Hipromelosa/química , Metilcelulosa/química , Polímeros/química , Agua/química , Fenómenos Químicos , Griseofulvina/metabolismo , Derivados de la Hipromelosa/metabolismo , Metilcelulosa/metabolismo , Soluciones Farmacéuticas/química , Soluciones Farmacéuticas/metabolismo , Polímeros/metabolismo , Solubilidad , Solventes/química , Solventes/metabolismo , Viscosidad , Agua/metabolismoRESUMEN
Characterization of wet-milled drug suspensions containing neutral polymer-anionic surfactant as stabilizers poses unique challenges in terms of assessing the aggregation state and examining the stabilization mechanisms. Using a multi-faceted characterization method, this study aims to assess the aggregation state of wet-milled griseofulvin (GF) nanosuspensions and elucidate the stabilization mechanisms and impact of stabilizers. Two grades, SSL and L, of hydroxypropyl cellulose (HPC) with molecular weights of 40 and 140 kg/mol, respectively, were used as a neutral stabilizer at concentrations varying from 0 to 7.5% (w/w) without and with 0.05% (w/w) sodium dodecyl sulfate (SDS). The aggregation state was examined via laser diffraction, scanning electron microscope (SEM) imaging, and rheometry. Zeta potential, stabilizer adsorption, surface tension, and drug wettability were used to elucidate the stabilization mechanisms. The results suggest that deviation from a uni-modal PSD and pronounced pseudoplasticity with power-law index lower than one signify severe aggregation. Polymer or surfactant alone was not able to prevent GF nanoparticle aggregation, whereas HPC-SDS combination led to synergistic stabilization. The effect of polymer concentration was explained mainly by the stabilizer adsorption and partly by surface tension. The synergistic stabilization afforded by HPC-SDS, traditionally explained by electrosteric mechanism, was attributed to steric stabilization provided by HPC and enhanced GF wettability/reduced surface tension provided by SDS. Zeta potential results could not explain the mitigation of aggregation by HPC-SDS. Overall, this study has demonstrated that the elucidation of the complex effects of HPC-SDS on GF nanosuspension stability entails a multi-faceted and comprehensive characterization approach.
Asunto(s)
Química Farmacéutica/métodos , Griseofulvina/química , Griseofulvina/metabolismo , Nanopartículas/química , Nanopartículas/metabolismo , Humectabilidad , Adsorción , Antifúngicos/química , Antifúngicos/metabolismo , Celulosa/análogos & derivados , Estabilidad de Medicamentos , Tamaño de la Partícula , Dodecil Sulfato de Sodio/química , Dodecil Sulfato de Sodio/metabolismo , Solubilidad , Tensoactivos , SuspensionesRESUMEN
The protein γ-tubulin plays an important role in centrosomal clustering and this makes it an attractive therapeutic target for treating cancers. Griseofulvin, an antifungal drug, has recently been used to inhibit proliferation of various types of cancer cells. It can also affect the microtubule dynamics by targeting the γ-tubulin protein. So far, the binding pockets of γ-tubulin protein are not properly identified and the exact mechanism by which the drug binds to it is an area of intense speculation and research. The aim of the present study is to investigate the binding mechanism and binding affinity of griseofulvin on γ-tubulin protein using classical molecular dynamics simulations. Since the drug griseofulvin is sparingly soluble in water, here we also present a promising approach for formulating and achieving delivery of hydrophobic griseofulvin drug via hydrotrope sodium cumene sulfonate (SCS) cluster. We observe that the binding pockets of γ-tubulin protein are mainly formed by the H8, H9 helices and S7, S8, S14 strands and the hydrophobic interactions between the drug and γ-tubulin protein drive the binding process. The release of the drug griseofulvin from the SCS cluster is confirmed by the coordination number analysis. We also find hydrotrope-induced alteration of the binding sites of γ-tubulin protein and the weakening of the drug-protein interactions.
Asunto(s)
Antifúngicos/metabolismo , Griseofulvina/metabolismo , Tubulina (Proteína)/metabolismo , Sitios de Unión , Enlace de HidrógenoRESUMEN
Griseofulvin, an orally active antifungal drug used to treat dermatophyte infections, has a secondary effect of inducing cytochrome P450-mediated production of N-methyl protoporphyrin IX (N-MPP). N-MPP is a potent competitive inhibitor of the heme biosynthetic-enzyme ferrochelatase, and inhibits the growth of cultured erythrocyte stage Plasmodium falciparum. Novel drugs against Plasmodium are needed to achieve malaria elimination. Thus, we investigated whether griseofulvin shows anti-plasmodial activity. We observed that the intraerythrocytic growth of P. falciparum is inhibited in red blood cells pretreated with griseofulvin in vitro. Treatment with 100 µM griseofulvin was sufficient to prevent parasite growth and induce the production of N-MPP. Inclusion of the ferrochelatase substrate PPIX blocked the inhibitory activity of griseofulvin, suggesting that griseofulvin exerts its activity through the N-MPP-dependent inhibition of ferrochelatase. In an ex-vivo study, red blood cells from griseofulvin-treated subjects were refractory to the growth of cultured P. falciparum. However, in a clinical trial griseofulvin failed to show either therapeutic or prophylactic effect in subjects infected with blood stage P. falciparum. Although the development of griseofulvin as an antimalarial is not warranted, it represents a novel inhibitor of P. falciparum growth and acts via the N-MPP-dependent inhibition of ferrochelatase.
Asunto(s)
Antifúngicos/uso terapéutico , Eritrocitos/parasitología , Ferroquelatasa/antagonistas & inhibidores , Griseofulvina/uso terapéutico , Malaria Falciparum/parasitología , Plasmodium falciparum/crecimiento & desarrollo , Adolescente , Adulto , Animales , Antifúngicos/metabolismo , Estudios de Casos y Controles , Estudios de Cohortes , Eritrocitos/efectos de los fármacos , Eritrocitos/metabolismo , Femenino , Estudios de Seguimiento , Griseofulvina/metabolismo , Humanos , Malaria Falciparum/tratamiento farmacológico , Malaria Falciparum/patología , Masculino , Persona de Mediana Edad , Proyectos Piloto , Plasmodium falciparum/efectos de los fármacos , Pronóstico , Adulto JovenRESUMEN
Analysis of complex mixtures is a common challenge in natural products research. Quantitative nuclear magnetic resonance spectroscopy offers analysis of complex mixtures at early stages and with benefits that are orthogonal to more common methods of quantitation, including ultraviolet absorption spectroscopy and mass spectrometry. Several experiments were conducted to construct a methodology for use in analysis of extracts of fungal cultures. A broadly applicable method was sought for analysis of both pure and complex samples through use of an externally calibrated method. This method has the benefit of not contaminating valuable samples with the calibrant, and it passed scrutiny for line fitting and reproducibility. The method was implemented to measure the yield of griseofulvin and dechlorogriseofulvin from three fungal isolates. An isolate of Xylaria cubensis (coded MSX48662) was found to biosynthesize griseofulvin in the greatest yield, 149 ± 8 mg per fermentation, and was selected for further supply experiments. Copyright © 2016 John Wiley & Sons, Ltd.
Asunto(s)
Productos Biológicos/análisis , Hongos/metabolismo , Espectroscopía de Resonancia Magnética/métodos , Antraquinonas/análisis , Antraquinonas/metabolismo , Ascomicetos/química , Ascomicetos/metabolismo , Productos Biológicos/metabolismo , Fermentación , Hongos/química , Griseofulvina/análisis , Griseofulvina/metabolismo , Metabolómica , Reproducibilidad de los Resultados , Metabolismo SecundarioRESUMEN
Nanosized formulations of poorly water-soluble drugs show great potential due to improved bioavailability. In order to retain colloidal stability, the nanocrystals need to be stabilized. Here we explore the use of the poly(ethylene glycol) (PEG) conjugated phospholipids DSPE-PEG2000 and DSPE-PEG5000 as stabilizers of felodipine and griseofulvin nanocrystals. Nanocrystal stability and physicochemical properties were examined and the interaction between the PEGylated lipids and the nanocrystal surface as well as a macroscopic model surface was investigated. Using quartz crystal microbalance with dissipation monitoring both mass adsorption and the thickness of the adsorbed layer were estimated. The results indicate that the PEGylated lipids are adsorbed as flat layers of around 1-3nm, and that DSPE-PEG5000 forms a thicker layer compared with DSPE-PEG2000. In addition, the mass adsorption to the drug crystals and the model surface are seemingly comparable. Furthermore, both DSPE-PEG2000 and DSPE-PEG5000 rendered stable drug nanocrystals, with a somewhat higher surface binding and stability seen for DSPE-PEG2000. These results suggest DSPE-PEG2000 and DSPE-PEG5000 as efficient nanocrystal stabilizers, with DSPE-PEG2000 giving a somewhat higher surface coverage and superior colloidal stability, whereas DSPE-PEG5000 shows a more extended structure that may have advantages for prolongation of circulation time in vivo and facilitation for targeting modifications.
Asunto(s)
Felodipino/metabolismo , Griseofulvina/metabolismo , Nanopartículas/metabolismo , Fosfatidiletanolaminas/metabolismo , Polietilenglicoles/metabolismo , Adsorción , Felodipino/química , Griseofulvina/química , Nanopartículas/química , Tamaño de la Partícula , Fosfatidiletanolaminas/química , Polietilenglicoles/química , Propiedades de SuperficieRESUMEN
We report two types of modifications to the natural product griseofulvin as strategies to improve solubility and metabolic stability: the conversion of aryl methyl ethers into aryl difluoromethyl ethers at metabolic hotspots and the conversion of the C-ring ketone into polar oximes. The syntheses of the analogues are described together with their solubility, metabolic half-life in vitro and antiproliferative effect in two cancer cell lines. We conclude that on balance, the formation of polar oximes is the most promising strategy for improving the properties of the analogues.
Asunto(s)
Antineoplásicos/química , Antineoplásicos/metabolismo , Griseofulvina/química , Griseofulvina/metabolismo , Animales , Antineoplásicos/síntesis química , Antineoplásicos/farmacología , Estabilidad de Medicamentos , Griseofulvina/síntesis química , Griseofulvina/farmacología , Células HeLa , Humanos , Masculino , Ratones , Microsomas/metabolismo , Oxidación-Reducción , Ratas , Solubilidad , Relación Estructura-Actividad , TermodinámicaRESUMEN
A set of biorelevant media "fasted-state simulated intestinal fluid with cholesterol (FaSSIF-C)" for the in vitro study of intestinal drug dissolution in the duodenum was developed. These contain cholesterol at the same levels as in human bile: the cholesterol content of FaSSIF-7C is equivalent to healthy female, FaSSIF-10C to healthy male persons, and FaSSIF-13C to several disease cases that lead to gallstones. The fluids were studied in three aspects: biocompatibility, intestinal nanostructure, and solubilizing power of hydrophobic drugs of the BCS class II. The biocompatibility study showed no toxic effects in a Caco-2 cell system. The drug-solubilizing capacity toward Fenofibrate, Danazol, Griseofulvin, and Carbamazepine was assessed as example. It varied with the cholesterol content widely from a fourfold improvement to a twofold reduction. The nanostructure study by dynamic light scattering and small-angle neutron scattering indicated vesicles as the main component of FaSSIF-C in equilibrium (>1 h), but at high cholesterol content, larger particles were observed as a minor contribution. The neutron experiments indicated the presence of complex micelle-vesicle mixtures, even after 1 h development of fed-state bile model to FaSSIF. The results indicate that cholesterol affects some drugs in solubilization and particle size in intestinal model fluids.
Asunto(s)
Líquidos Corporales/metabolismo , Colesterol/metabolismo , Ayuno/metabolismo , Mucosa Intestinal/metabolismo , Células CACO-2 , Carbamazepina/metabolismo , Danazol/metabolismo , Sistemas de Liberación de Medicamentos/métodos , Femenino , Fenofibrato/metabolismo , Griseofulvina/metabolismo , Humanos , Absorción Intestinal/fisiología , Masculino , Modelos Teóricos , Tamaño de la Partícula , SolubilidadRESUMEN
RATIONALE: Griseofulvin is an antifungal agent with potential for misuse in food-producing animals. Little is known about its metabolism in ruminants and hence what are suitable marker residues and target matrices for monitoring purposes. METHODS: Tissues harvested from cattle treated with the antifungal agent griseofulvin were screened using liquid chromatography coupled to positive and negative electrospray ionization (ESI) quadrupole time-of-flight mass spectrometry (qToFMS) operated in ToF mode. RESULTS: Twenty-five possible metabolites were detected across all tissue types, but two isomeric compounds with accurate masses corresponding to loss of a methyl group from parent griseofulvin were considered to be the best candidate markers. Data from fragmentation experiments enabled a tentative assignment of the structures of the two compounds as 4-demethylgriseofulvin and 6-demethylgriseofulvin. These assignments were confirmed by matching the product ion spectra of incurred residues to those of custom synthesized reference standards. CONCLUSIONS: 4-Demethyl- and 6-demethylgriseofulvin have been identified as potential marker compounds of griseofulvin use in cattle. Liver was identified as the target matrix. Hair was shown to have potential for non-invasive testing.
Asunto(s)
Antifúngicos/análisis , Enfermedades de los Bovinos/metabolismo , Cromatografía Líquida de Alta Presión/métodos , Griseofulvina/análisis , Espectrometría de Masas en Tándem/métodos , Drogas Veterinarias/análisis , Animales , Antifúngicos/metabolismo , Antifúngicos/uso terapéutico , Biomarcadores/análisis , Biomarcadores/metabolismo , Bovinos , Enfermedades de los Bovinos/tratamiento farmacológico , Griseofulvina/metabolismo , Griseofulvina/uso terapéutico , Cabello/química , Cabello/metabolismo , Hígado/química , Hígado/metabolismo , Espectrometría de Masa por Ionización de Electrospray/métodos , Drogas Veterinarias/metabolismoRESUMEN
The improvement of the bioavailability of poorly soluble drugs has been an important issue in pharmaceutical research for many years. Despite the suggestion of several other technologies in the past, drug particle size reduction is still an appropriate strategy to guarantee high bioavailability of various drugs. A few years ago, the Solid Crystal Suspension (SCS) technology was suggested, in which crystalline drug particles are ground and dispersed in a highly soluble crystalline carrier by a hot melt extrusion process. The current study demonstrates the scale-up of the SCS technology to standard, lab-scale extrusion equipment--a change from previous investigations, which used small batch sizes. A twin-screw extruder was modified to account for the rapid crystallization of the carrier. The screw speed and the barrel temperature were identified as critical process parameters and were varied systematically in several experimental designs. Finally, parameters were identified that produced extrudates with rapid dissolution rates. After extrusion, the extrudates were milled to granules and then tableted. These tablets were investigated with respect to their bioavailability in beagle dogs. It was found that drug particle size reduction in the hot melt extrusion led to 3.5-fold higher bioavailability in these dogs than occurred with the physical mixture of the used substances. The solid crystal suspension formulation had a slightly higher bioavailability than the marked product. In conclusion, the SCS technology was successfully scaled up to lab-scale equipment, and the concept was confirmed by a bioavailability study.
Asunto(s)
Griseofulvina/química , Griseofulvina/metabolismo , Suspensiones/química , Suspensiones/metabolismo , Animales , Disponibilidad Biológica , Química Farmacéutica/métodos , Cristalización/métodos , Perros , Portadores de Fármacos/química , Portadores de Fármacos/metabolismo , Calor , Tamaño de la Partícula , Solubilidad , Comprimidos/química , Comprimidos/metabolismoRESUMEN
PURPOSE: The bile acids, phospholipids, inorganic ions, and pH in luminal fluid are very important factors for the dissolution and oral absorption of solid drugs. In this study, we evaluated the regional differences in these factors in the rat GI tract. The solubility of griseofulvin, a poorly water-soluble drug, in the luminal fluid in each segment was also measured. In addition, the data from rats were compared with those from other species published previously to evaluate the species differences in the composition of luminal fluid. METHODS: Rat abdomen was opened and residual water was sampled from each region of GI tract to measure the various components concentrations. RESULTS: The total bile acid and phospholipid concentrations were much higher in the lower jejunum and upper jejunum, respectively, than in the other regions. The solubilities of griseofulvin in the lower jejunal fluid (153-260 ug/mL) were about 1.5-2 times higher than those in the upper jejunal fluid (99-146 ug/mL). The regional differences in inorganic ions and pH were also observed. As for species differences, the total bile acid and phospholipid concentration in rats GI tract were much higher than those of dogs and humans. CONCLUSION: These informations about the regional differences and species differences of the components in the GI fluid should be very useful to consider dissolution and oral absorption of solid drugs.
Asunto(s)
Ácidos y Sales Biliares/metabolismo , Líquidos Corporales/metabolismo , Mucosa Gástrica/metabolismo , Griseofulvina/metabolismo , Yeyuno/metabolismo , Administración Oral , Animales , Perros , Humanos , Concentración de Iones de Hidrógeno , Iones/metabolismo , Masculino , Fosfolípidos/metabolismo , Ratas , Ratas Wistar , SolubilidadRESUMEN
As 95% of all prescriptions are for orally administered drugs, the issue of oral absorption is central to the development of pharmaceuticals. Oral absorption is limited by a high molecular weight (>500 Da), a high log P value (>2.0) and low gastrointestinal permeability. We have designed a triple action nanomedicine from a chitosan amphiphile: quaternary ammonium palmitoyl glycol chitosan (GCPQ), which significantly enhances the oral absorption of hydrophobic drugs (e.g., griseofulvin and cyclosporin A) and, to a lesser extent, the absorption of hydrophilic drugs (e.g., ranitidine). The griseofulvin and cyclosporin A C(max) was increased 6- and 5-fold respectively with this new nanomedicine. Hydrophobic drug absorption is facilitated by the nanomedicine: (a) increasing the dissolution rate of hydrophobic molecules, (b) adhering to and penetrating the mucus layer and thus enabling intimate contact between the drug and the gastrointestinal epithelium absorptive cells, and (c) enhancing the transcellular transport of hydrophobic compounds. Although the C(max) of ranitidine was enhanced by 80% with the nanomedicine, there was no appreciable opening of tight junctions by the polymer particles.
Asunto(s)
Quitosano/análogos & derivados , Ciclosporina/administración & dosificación , Portadores de Fármacos/administración & dosificación , Griseofulvina/administración & dosificación , Absorción Intestinal , Nanopartículas/química , Compuestos de Amonio Cuaternario/química , Adhesividad , Animales , Antiulcerosos/administración & dosificación , Antiulcerosos/sangre , Antiulcerosos/metabolismo , Antiulcerosos/farmacocinética , Antibióticos Antineoplásicos/administración & dosificación , Antibióticos Antineoplásicos/metabolismo , Antibióticos Antineoplásicos/farmacocinética , Antifúngicos/administración & dosificación , Antifúngicos/sangre , Antifúngicos/metabolismo , Antifúngicos/farmacocinética , Células CACO-2 , Quitosano/química , Ciclosporina/sangre , Ciclosporina/metabolismo , Ciclosporina/farmacocinética , Portadores de Fármacos/análisis , Portadores de Fármacos/metabolismo , Portadores de Fármacos/farmacocinética , Griseofulvina/sangre , Griseofulvina/metabolismo , Griseofulvina/farmacocinética , Humanos , Interacciones Hidrofóbicas e Hidrofílicas , Idarrubicina/administración & dosificación , Idarrubicina/metabolismo , Idarrubicina/farmacocinética , Mucosa Intestinal/citología , Mucosa Intestinal/metabolismo , Intestino Delgado/citología , Intestino Delgado/metabolismo , Masculino , Nanopartículas/ultraestructura , Ranitidina/administración & dosificación , Ranitidina/sangre , Ranitidina/metabolismo , Ranitidina/farmacocinética , Ratas , Ratas WistarRESUMEN
Griseofulvin, an antifungal agent, is a BCS class II drug slowly, erratically, and incompletely absorbed from the gastrointestinal tract in humans. The clinical failure of the conventional oral therapy of griseofulvin is most likely attributed to its poor solubility and appreciable inter- and intra-subject variation in bioavailability from different commercial products. Moreover, the conventional oral therapy is associated with numerous adverse effects and interactions with other drugs. The purpose of the study was to formulate a topical application of griseofulvin which would deliver the drug locally in a therapeutically effective concentration. Griseofulvin was solubilized in ethanol, D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), and combinations of ethanol with varying amounts of TPGS; then, it was incorporated in the Carbopol (980 NF) base. The formulations were characterized and evaluated ex vivo using Laca mice skin, microbiologically against Microsporum gypseum and Microsporum canis and clinically in a small group of patients. The current study suggested that TPGS and ethanol synergistically enhanced the drug permeation and drug retention in the skin. The selected formulation F VII was found to be effective against M. gypseum and M. canis, non-sensitizing, histopathologically safe, stable at 4°C, 25°C, and 40°C with respect to percent drug content, permeation characteristics, pH, transparency, feel, viscosity, and clinically effective in a small group of subjects. The proposed topical formulation of griseofulvin may be an effective and convenient alternative to the currently available oral therapy for the treatment of superficial fungal infections.
Asunto(s)
Griseofulvina/administración & dosificación , Griseofulvina/síntesis química , Absorción Cutánea/efectos de los fármacos , Vitamina E/análogos & derivados , Administración Cutánea , Adulto , Animales , Evaluación Preclínica de Medicamentos/métodos , Femenino , Griseofulvina/metabolismo , Humanos , Masculino , Ratones , Micosis/tratamiento farmacológico , Micosis/metabolismo , Micosis/patología , Pruebas del Parche/métodos , Polietilenglicoles/administración & dosificación , Polietilenglicoles/síntesis química , Polietilenglicoles/metabolismo , Absorción Cutánea/fisiología , Vitamina E/administración & dosificación , Vitamina E/síntesis química , Vitamina E/metabolismo , Adulto JovenRESUMEN
An amino-acid-based hydrophobically modified biocompatible copolymer, poly[(sodium N-acryloyl-L-valinate)-co-(N-octylacrylamide)] was synthesized and characterized. Techniques such as fluorescence probes, DLS, and TEM were used to investigate its aggregation behavior in aqueous solution. The copolymer was observed to form micellar aggregates having diameters in the nanometer range in aqueous solution (pH = 8) through inter-chain hydrophobic association. This behavior was found to be similar to that of poly[(sodium N-acryloyl-L-valinate)-co-(N-dodecylacrylamide)]. The compact micellar nanostructures were observed to be stable with respect to changes of pH and temperature. The encapsulation and release of griseofulvin, a hydrophobic model drug, was studied.